Farfel Gail M
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Farfel Gail M. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| 0001082038 | U | 15,500 | — | — | Sep 11, 2025 | |
| 0001082038 | Option Exercise | 5,500 | $1.22 | $6,710 | Sep 10, 2025 | |
| PMN | Chief Executive Officer | Award / Grant | 53,192 | — | — | Aug 23, 2023 |
| PMN | Chief Executive Officer | Purchase | 1,000 | $4.94 | $4,940 | Dec 14, 2022 |
| PMN | Chief Executive Officer | Purchase | 1,000 | $5.70 | $5,700 | Dec 6, 2022 |
| 0001082038 | Purchase | 25,300 | $0.39 | $9,867 | May 18, 2022 | |
| 0001082038 | Purchase | 1,500 | $0.39 | $585 | May 11, 2022 | |
| 0001082038 | Purchase | 2,339 | $0.41 | $959 | May 10, 2022 | |
| 0001082038 | Purchase | 4,250 | $0.40 | $1,700 | May 9, 2022 | |
| 0001375151 | See Remarks | U | 16,606 | — | — | Mar 7, 2022 |
| 0001375151 | EVP/Chief Development Officer | Tax Withholding | 542 | $20.70 | $11,219 | Mar 15, 2021 |
| 0001375151 | EVP/Chief Development Officer | Tax Withholding | 3,044 | — | — | Jun 25, 2020 |
| 0001375151 | EVP/Chief Development Officer | Sale | 2,573 | $28.21 | $72,584 | May 12, 2020 |
| 0001375151 | EVP/Chief Development Officer | Tax Withholding | 525 | $22.01 | $11,555 | Mar 15, 2020 |
| 0001375151 | EVP/Chief Development Officer | Sale | 3,446 | $52.00 | $179,192 | Aug 22, 2019 |
| 0001375151 | EVP/Chief Development Officer | Tax Withholding | 488 | $51.88 | $25,317 | Mar 15, 2019 |
| 0001375151 | EVP/Chief Development Officer | Sale | 1,961 | $43.74 | $85,774 | Oct 4, 2018 |
| 0001375151 | EVP/Chief Development Officer | Option Exercise | 7,000 | $13.96 | $97,720 | Sep 4, 2018 |
| 0001375151 | EVP/Chief Development Officer | Sale | 5,100 | $52.42 | $267,342 | Aug 8, 2018 |
| 0001375151 | EVP/Chief Development Officer | Sale | 5,118 | $45.00 | $230,310 | Jun 12, 2018 |
| 0001267813 | Chief Clinical Dev & Reg Offic | Option Exercise | 30,000 | $1.04 | $31,200 | Apr 21, 2015 |